Section Arrow
AWH.NASDAQ
- Aspira Women's Health
Quotes are at least 15-min delayed:2024/05/20 15:25 EDT
Last
 2.5301
-0.1299 (-4.88%)
Day High 
2.65 
Prev. Close
2.66 
1-M High
3.57 
Volume 
60.07K 
Bid
2.53
Ask
2.54
Day Low
2.17 
Open
2.65 
1-M Low
2.62 
Market Cap 
32.84M 
Currency USD 
P/E -- 
%Yield
10-SMA 2.9 
20-SMA 3.11 
50-SMA 3.25 
52-W High 6.75 
52-W Low 2.3087 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.41/-0.50
Enterprise Value
34.69M
Balance Sheet
Book Value Per Share
-0.11
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
9.15M
Operating Revenue Per Share
0.73
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DMTKDermTech0.3632-0.1363-27.29%-- 
EXASExact Sciences Corp51.209+0.829+1.65%-- 
GHGuardant Health24.59-0.77-3.04%-- 
OPKOPKO Health1.32--0.000%-- 
LABStandard BioTools2.575+0.005+0.19%-- 
Quotes are at least 15-min delayed:2024/05/20 15:25 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.